University of Antwerp, Department of Medicine, Antwerp, Belgium.
Department of Endocrinology, Diabetology & Metabolism, Antwerp University Hospital, Edegem, Belgium.
Int J Obes (Lond). 2017 Nov;41(11):1615-1620. doi: 10.1038/ijo.2017.165. Epub 2017 Jul 19.
Type 2 diabetes (T2DM) is known to be underdiagnosed. Tests for diagnosis include fasting plasma glucose (FPG), oral glucose tolerance test (OGTT) and HbA1c. HbA1c can be tested in non-fasting conditions. Therefore, general practitioners almost no longer execute OGTT's. We evaluated the performance of OGTT versus HbA1c in a population consisting of overweight and obese subjects, which can be considered a 'high risk' population.
A total of, 1241 overweight and obese subjects without a history of diabetes (male/female: 375/866, age 44±13 years, body mass index 38.0±6.1 kg m) were tested for glucose tolerance status using FPG, OGTT and HbA1c.
Exactly, 46.8% were found to have prediabetes and 11.9% were newly diagnosed with T2DM (male/female=18.9/8.9%) using ADA criteria. Testing only HbA1c would have resulted in 78 subjects being diagnosed with T2DM, but 47.3% of newly diagnosed patients would have been missed if OGTT would not have been done. Exactly 581 subjects were diagnosed with prediabetes, 1.4% subjects had impaired fasting glucose (IFG) 30.5% had impaired glucose tolerance (IGT), 5.1% subjects had a combined IFG+IGT, and 9.8% had an isolated elevated HbA1c (5.7-6.4%). Of the 581 subjects with prediabetes, 257 had an HbA1c <5.7%. Therefore, 44.2% subjects would have been missed when OGTT would not have been done.
In a population with only overweight and obese adult subjects, 46.8% were diagnosed with prediabetes and 11.9% were newly diagnosed with diabetes. Exactly, 5.6 and 20.7% of total population met the diagnostic criteria of the OGTT for diabetes and prediabetes, respectively, but did not meet the diagnostic criteria of the HbA1c. These data suggest that not performing an OGTT results in significant underdiagnose of T2DM in an overweight and obese adult population.
已知 2 型糖尿病(T2DM)漏诊率较高。诊断检测包括空腹血糖(FPG)、口服葡萄糖耐量试验(OGTT)和糖化血红蛋白(HbA1c)。HbA1c 可在非空腹条件下进行检测。因此,全科医生几乎不再进行 OGTT。我们评估了 OGTT 与 HbA1c 在超重和肥胖人群中的表现,这些人群可被视为“高危”人群。
共对 1241 名无糖尿病史的超重和肥胖受试者(男性/女性:375/866,年龄 44±13 岁,体重指数 38.0±6.1kg/m²)进行 FPG、OGTT 和 HbA1c 葡萄糖耐量状态检测。
ADA 标准下,46.8%的受试者被诊断为糖尿病前期,11.9%的受试者被新诊断为 T2DM(男性/女性=18.9/8.9%)。仅检测 HbA1c 会导致 78 例 T2DM 被诊断,但如果不进行 OGTT,则会漏诊 47.3%的新诊断患者。共有 581 例受试者被诊断为糖尿病前期,1.4%的受试者存在空腹血糖受损(IFG),30.5%的受试者存在葡萄糖耐量受损(IGT),5.1%的受试者存在 IFG+IGT 联合,9.8%的受试者存在 HbA1c 升高(5.7-6.4%)。在 581 例糖尿病前期患者中,257 例 HbA1c<5.7%。因此,如果不进行 OGTT,会漏诊 44.2%的受试者。
在仅有超重和肥胖成年受试者的人群中,46.8%被诊断为糖尿病前期,11.9%被新诊断为糖尿病。确切地说,5.6%和 20.7%的总体人群分别符合 OGTT 对糖尿病和糖尿病前期的诊断标准,但不符合 HbA1c 的诊断标准。这些数据表明,在超重和肥胖的成年人群中,如果不进行 OGTT,会导致 T2DM 的严重漏诊。